World
The round was co-led by investors including D. E. Shaw Ventures, ICONIQ, and MGX.
1
Singapore chases 'growth' IPOs as Hong Kong attracts AI listings
2
China's GDS affiliate DayOne aims to raise $5b in US IPO
3
India's Alkem Labs unit to buy up to 55% of Occlutech for $118m
4
Japan's Sumitomo Forestry to buy US builder Tri Pointe Homes for $4.5b
5
India's Ola Electric posts narrower loss despite sales slump
More Stories
Singapore to roll out second tranche of $1.2-billion Anchor Fund
How Singapore’s markets are primed for 2026
65 Equity-backed UltraGreen.ai debuts on SGX after $400m IPO
CVC in early talks to invest in Indonesian retail conglomerate MAP Group
From rides to riches: Grab places bets beyond its comfort zone
India
With Fund II, W Health plans to build and scale 8-10 new companies over the next four years.
Singapore
The round was anchored by VC firm Gobi Partners.
The startup in focus helps manufacturers automate quality checks using AI.
Malaysia
The company has raised a total of nearly $6 million since inception.
Greater China
There was strong investor appetite for policy-aligned industries like software and semiconductor.
Existing investors, including Polaris Partners and SEEDS Capital, backed the round.
About 50% of the capital in its fourth fund has come from global LPs.
The capital proceeds will accelerate the clinical development of Ciraparantag.
The funding was led by Sofina and Sauce.vc.